Advertisement

Moderation of the Effect of Adolescent-Onset Cannabis Use on Adult Psychosis by a Functional Polymorphism in the Catechol-O-Methyltransferase Gene: Longitudinal Evidence of a Gene X Environment Interaction

      Background

      Recent evidence documents that cannabis use by young people is a modest statistical risk factor for psychotic symptoms in adulthood, such as hallucinations and delusions, as well as clinically significant schizophrenia. The vast majority of cannabis users do not develop psychosis, however, prompting us to hypothesize that some people are genetically vulnerable to the deleterious effects of cannabis.

      Methods

      In a longitudinal study of a representative birth cohort followed to adulthood, we tested why cannabis use is associated with the emergence of psychosis in a minority of users, but not in others.

      Results

      A functional polymorphism in the catechol-O-methyltransferase (COMT) gene moderated the influence of adolescent cannabis use on developing adult psychosis. Carriers of the COMT valine158 allele were most likely to exhibit psychotic symptoms and to develop schizophreniform disorder if they used cannabis. Cannabis use had no such adverse influence on individuals with two copies of the methionine allele.

      Conclusions

      These findings provide evidence of a gene × environment interaction and suggest that a role of some susceptibility genes is to influence vulnerability to environmental pathogens.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Akil M.
        • Kolachana B.S.
        • Rothmond D.A.
        • Hyde T.M.
        • Weinberger D.R.
        • Kleinman J.E.
        Catechol-O-methyltransferase genotype and dopamine regulation in the human brain.
        J Neuroscience. 2003; 23: 2008-2013
        • American Psychiatric Association
        Diagnostic and Statistical Manual of Mental Disorders. 4th ed. American Psychiatric Association, Washington, DC1994
        • Arseneault L.
        • Cannon M.
        • Witton J.
        • Murray R.M.
        Causal association between cannabis and psychosis.
        Br J Psychiatry. 2004; 184: 110-117
        • Ashton H.
        Cannabis or health?.
        Curr Opin Psychiatry. 2002; 15: 247-253
        • Bilder R.M.
        • Volavka J.
        • Lachman H.M.
        • Grace A.
        The catechol-O-methyltransferase polymorphism.
        Neuropsychopharmacology. 2004; 29: 1943-1961
        • Block R.I.
        • O’Leary D.S.
        • Hichwa R.D.
        • Augustinack J.C.
        • Boles Ponto L.L.
        • Ghoneim M.M.
        • et al.
        Effects of frequent marijuana use on memory-related regional cerebral blood flow.
        Pharmacol Biochem Behavior. 2002; 72: 237-250
        • Blumstein A.
        Youth violence, guns, and the illicit-drug industry.
        J Crim Law Criminol. 1995; 86: 10-36
        • Bray N.J.
        • Buckland P.R.
        • Williams N.M.
        • Williams H.J.
        • Norton N.
        • Owen M.J.
        • et al.
        A haplotype implicated in schizophrenia susceptibility is associated with reduced COMT expression in human brain.
        Am J Hum Genet. 2003; 73: 152-161
        • Bunney W.E.
        • Bunney B.G.
        Evidence for a compromised dorsolateral prefrontal cortical parallel circuit in schizophrenia.
        Brain Res Rev. 2000; 31: 138-146
        • Cannon M.
        • Caspi A.
        • Moffitt T.E.
        • Murray R.
        • Harrington H.
        • Poulton R.
        Evidence for early-childhood, pan-developmental impairment specific to adult schizophreniform disorder.
        Arch Gen Psychiatry. 2002; 59: 449-456
        • Carlsson A.
        • Waters N.
        • Holm-Waters S.
        • Tedroff J.
        • Nilsson M.
        • Carlsson M.L.
        Interactions between monoamines, glutomate, and GABA in schizophrenia.
        Ann Rev Pharmacol Toxicol. 2001; 41: 237-260
        • Caspi A.
        • McClay J.
        • Moffitt T.E.
        • Mill J.
        • Martin J.
        • Craig I.W.
        • et al.
        Role of genotype in the cycle of violence in maltreated children.
        Science. 2002; 297: 851-854
        • Caspi A.
        • Sugden K.
        • Moffitt T.E.
        • Taylor A.
        • Craig I.W.
        • Harrington H.
        • et al.
        Influence of life stress on depression.
        Science. 2003; 301: 386-389
        • Chambers R.A.
        • Taylor J.R.
        • Potenza M.C.
        Developmental neurocircuitry of motivation in adolescence.
        Am. J Psychiatry. 2003; 160: 1041-1052
        • Cohen J.
        • Cohen P.
        • West S.G.
        • Aiken L.S.
        Applied multiple regression/correlation analysis for the behavioral sciences. Erlbaum, Hillsdale, NJ2003
        • Di Maggio C.
        • Martinez M.
        • Menard J.-F.
        • Petit M.
        • Thibaut F.
        Evidence of a cohort effect for age at onset of schizophrenia.
        Am J Psychiatry. 2001; 158: 489-492
        • Egan M.F.
        • Goldberg T.E.
        • Kolachana B.S.
        • Callicott J.H.
        • Mazzanti C.M.
        • Straub R.E.
        • et al.
        Effect of COMT val 108/158 genotype on frontal lobe function and risk for schizophrenia.
        PNAS. 2001; 98: 6917-6922
        • Erhrenreich H.
        • Rinn T.
        • Kunert H.J.
        • Moeller M.R.
        • Poser W.
        • Schilling L.
        • et al.
        Specific attentional dysfunction in adults following early start of cannabis use.
        Psychopharmacology. 1999; 142: 295-301
        • Foley D.L.
        • Eaves L.J.
        • Wormley B.
        • Silberg J.L.
        • Maes H.H.
        • Kuhn J.
        • et al.
        Childhood adversity, monoamine oxidase A genotype, and risk for conduct disorder.
        Arch Gen Psychiatry. 2004; 61: 738-744
        • Glatt S.J.
        • Faraone S.V.
        • Tsuang M.T.
        Association between a functional catechol-O-methyltransferase gene polymorphism and schizophrenia.
        Am J Psychiatry. 2003; 160: 469-476
        • Gottesman I.I.
        • Gould T.D.
        The endophenotype concept in psychiatry.
        Am J Psychiatry. 2003; 160: 636-645
        • Hardin J.
        • Hilbe J.
        Generalized linear models and extensions. Stata Press, College Station, TX2001
      1. Henquet C, Krabbendam L, Spauwen J, Kaplan C, Lieb R, Wittchen H-U, et al (2004): Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. Br Med J. Available: BMJ, doi:10.1136/bmj.38267.664086.63 (published 1 December 2004).

        • Iversen L.
        Cannabis and the brain.
        Brain. 2003; 126: 1252-1270
        • Johns L.C.
        • van Os J.
        The continuity of psychotic experiences in the general population.
        Clinical Psychol Rev. 2001; 21: 1125-1141
        • Kapur S.
        Psychosis as a state of aberrant salience.
        Am J Psychiatry. 2003; 160: 13-23
      2. Kendler KS, Kuhn JW, Vittum J, Prescott CA, Riley B (in press): The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression: A replication. Arch Gen Psychiatry.

        • Kennedy J.L.
        • Farrer L.A.
        • Andreasen N.C.
        • Mayeux R.
        • St. George-Hyslop P.
        The genetics of adult-onset neuropsychiatric disease.
        Science. 2003; 302: 822-826
        • Kim-Cohen J.
        • Caspi A.
        • Moffitt T.E.
        • Harrington H.
        • Milne B.
        • Poulton R.
        Prior juvenile diagnoses in adults with mental disorder.
        Arch Gen Psychiatry. 2003; 60: 709-717
        • Lachman H.M.
        • Papolos D.F.
        • Saito T.
        • Yu Y.M.
        • Szumlanski C.L.
        • Weinshilboum R.M.
        Human catechol-O-methyltransferase pharmacogenetics.
        Pharmacogenetics. 1996; 6: 243-250
        • Lewis C.M.
        • Levinson D.F.
        • Wise L.H.
        • DeLisi L.E.
        • Straub R.E.
        • Hovatta I.
        • et al.
        Genome scan meta-analysis of schizophrenia and bipolar disorder, Part II.
        Am J Hum Genet. 2003; 73: 34-48
        • Licinio J.
        Moving away from one-polymorphism genetic association studies.
        Mol Psychiatry. 2003; 8: 247
        • Lotta T.
        • Vidgren J.
        • Tilgmann C.
        • Ulmanen I.
        • Melen K.
        • Julkenen I.
        • et al.
        Kinetics of human soluble and membrane-bound catechol-O-methyltransferase.
        Biochemistry. 1995; 34: 4202-4210
        • Lundqvist T.
        • Jonsson S.
        • Warkentin S.
        Frontal lobe dysfunction in long-term cannabis users.
        Neurotoxicol Teratol. 2001; 23: 437-443
        • Lynskey M.T.
        • Heath A.C.
        • Bucholz K.K.
        • Slutske W.S.
        • Madden P.A.F.
        • Nelson E.C.
        • et al.
        Escalation of drug use in early-onset cannabis users vs co-twin controls.
        JAMA. 2003; 289: 427-433
        • Männisto P.T.
        • Kaakkola S.
        Catechol-O-methyltransferase (COMT).
        Pharmacol Rev. 1999; 51: 593-628
        • McClay J.
        • Sugden K.
        • Koch H.
        • Higuchi S.
        • Craig I.W.
        High-throughput single-nucleotide polymorphism genotyping by fluorescent competitive allele-specific polymerase chain reaction (SNiPTag).
        Anal Biochem. 2002; 301: 200-206
      3. Moffitt TE, Caspi A, RutterM(in press): Strategy for investigating interactions between measured genes and measured environments. Arch Gen Psychiatry.

        • Moffitt T.E.
        • Caspi A.
        • Rutter M.
        • Silva P.A.
        Sex Differences in Antisocial Behaviour. Cambridge University Press, Cambridge2001
        • Moore H.
        • West A.R.
        • Grace A.A.
        The regulation of forebrain dopamine transmission.
        Biol Psychiatry. 1999; 46: 40-55
        • Murphy K.C.
        • Jones L.A.
        • Owen M.J.
        High rates of schizophrenia in adults with velo-cardio-facial syndrome.
        Arch Gen Psychiatry. 1999; 56: 940-945
        • Myin-Germeys I.
        • Krabbendam L.
        • van Os J.
        Continuity of psychotic symptoms in the community.
        Curr Opin Psychiatry. 2003; 16: 443-449
        • Ordovas J.M.
        • Corella D.
        • Demissie S.
        • Cupples L.A.
        • Couture P.
        • Coltell O.
        • et al.
        Dietary fat intake determines the effect of a common polymorphism in the hepatic lipase gene promoter on high-density lipoprotein metabolism.
        Circulation. 2002; 106: 2315-2321
        • Owen M.J.
        • Williams N.M.
        • O’Donovan M.C.
        The molecular genetics of schizophrenia.
        Mol Psychiatry. 2004; 9: 14-27
        • Palmatier M.A.
        • Kang A.M.
        • Kidd K.K.
        Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles.
        Biol Psychiatry. 1999; 46: 557-567
        • Pistis M.
        • Perra S.
        • Pillolla G.
        • Melia M.
        • Muntoni A.L.
        • Gessa G.L.
        Adolescent exposure to cannabinoids induces long-lasting changes in the response to drugs of abuse of rat midbrain dopamine neurons.
        Biol Psychiatry. 2004; 56: 86-94
        • Pope H.G.
        • Gruber A.J.
        • Hudson J.I.
        • Cohane G.
        • Huestis M.A.
        • Yurgelun-Todd D.
        Early-onset cannabis use and cognitive deficits.
        Drug Alcohol Depend. 2003; 69: 303-310
        • Poulton R.
        • Caspi A.
        • Moffitt T.E.
        • Cannon M.
        • Murray R.
        • Harrington H.
        Children’s self-reported psychotic symptoms predict adult schizophreniform disorders.
        Arch Gen Psychiatry. 2000; 57: 1053-1058
        • Rhee S.H.
        • Hewitt J.K.
        • Young S.E.
        • Corley R.P.
        • Crowley T.J.
        • Stallings M.C.
        Genetic and environmental influences on substance initiation, use, and problem use in adolescents.
        Arch Gen Psychiatry. 2003; 60: 1256-1264
        • Robins L.N.
        • Cottler L.
        • Bucholtz K.
        • Compton W.
        Diagnostic Interview Schedule for DSM-IV. Washington University, St. Louis, MO1995
        • Schneider M.
        • Koch M.
        Chronic pubertal, but not adult chronic cannabinoid treatment impairs sensorimotor gating, recognition memory, and the performance in a progressive ratio task in adult rats.
        Neuropsychopharmacology. 2003; 28: 1760-1769
        • Shifman S.
        • Bronstein M.
        • Sternfeld M.
        • Pisanté-Shalom A.
        • Lev-Lehman E.
        • Weizman A.
        • et al.
        A highly-significant association between a COMT haplotype and schizophrenia.
        Am J Hum Genet. 2002; 71: 1296-1302
        • Solowij N.
        • Stephens R.S.
        • Roffman R.A.
        • Babor T.
        • Kadden R.
        • Miller M.
        • et al.
        Cognitive functioning of long-term heavy cannabis users seeking treatment.
        JAMA. 2002; 287: 1123-1131
        • StataCorp
        Stata statistical software. Author, College Station, TX2003
        • Stefanis N.C.
        • Delespaul P.
        • Henquet C.
        • Bakoula C.
        • Stefanis C.N.
        • van Os J.
        Early adolescent cannabis exposure and positive and negative dimensions of psychosis.
        Addiction. 2004; 99: 1333-1341
        • Tanda G.
        • Poitieri F.E.
        • Di Chiara G.
        Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common μ1 opioid receptor mechanism.
        Science. 1997; 276: 2048-2050
        • Van Os J.
        • Bak M.
        • Bijl R.V.
        • De Graaf R.
        • Verdoux H.
        Cannabis use and psychosis.
        Am J Epid. 2002; 156: 319-327
        • Veen N.D.
        • Selten J.-P.
        • van der Tweel I.
        • Feller W.G.
        • Hoek H.W.
        • Kahn R.S.
        Cannabis use and age at onset of schizophrenia.
        Am J Psychiatry. 2004; 161: 501-506
        • Verdoux H.
        • Gindre C.
        • Sorbara F.
        • Tournier M.
        • Swendsen J.D.
        Effects of cannabis and psychosis vulnerability in daily life.
        Psychol Med. 2003; 33: 23-32
        • Verrico C.D.
        • Jentsch J.D.
        • Roth R.H.
        Persistent and anatomically selective reduction in prefrontal cortical dopamine metabolism after repeated intermittent cannabinoid administration to rats.
        Synapse. 2003; 49: 61-66
        • Voruganti L.N.P.
        • Slomka P.
        • Zabel P.
        • Mattar A.
        • Awad A.G.
        Cannabis induced dopamine release.
        Psychiatr Res. 2001; 107: 173-177
        • Wechsler D.
        Wechsler Intelligence Scale for Children—Revised (manual). Psychological Corporation, New York1974
        • Weinberger D.R.
        • Egan M.F.
        • Bertolino A.
        • Callicott J.H.
        • Mattay V.S.
        • Lipska B.K.
        • et al.
        Prefrontal neurons and the genetics of schizophrenia.
        Biol Psychiatry. 2001; 50: 825-844